InternationalUSRemember you can easily switch between MIP US and MIP International at any time

What's on this week

Managing Intellectual Property


Managing IP lists the IP meetings, decisions and events taking place this week

Monday May 21

Hearing begins in Samsung Electronics (UK) Limited and Anr v Apple Inc at the Court of Appeal in London.

WIPO’s Standing Committee on the Law of Patents (eighteenth session) meets from Monday to Friday in Geneva.

OHIM hosts the 7th Trade Marks Liaison meeting between OHIM officials and representatives of EU national IP offices in Alicante.

The Korean...


Please log in to read the rest of this article.

New to Managing Intellectual Property? Take advantage of one week’s FREE access and become a Managing IP member today. It’s free to join and the benefits start straight away.

Already registered?

Please make sure you log in to read the rest of the article.

Log in

Join us now

Gain 7 days FREE access when you register now.

Join here

profile

Managing IP

ManagingIP

ManagingIP profile

RT @patentbuddy: An Indian Outsourcing Company, Dulcera, with No Patents Won the USPTO's "Cancer Moonshot Challenge": https://t.co/52qGwz7

Sep 28 2016 05:09 ·  reply ·  retweet ·  favourite
ManagingIP profile

One more day until our #tradesecrets #DTSA webinar - don't miss out; sign up here! https://t.co/gh3Ka8t9q1https://t.co/muV4Q0nZWn

Sep 28 2016 05:07 ·  reply ·  retweet ·  favourite
ManagingIP profile

Royalties for unpatented tech - Genentech case analysed by Richard Binns & Nicola Walles of @SimmonsLLP ($/trial) https://t.co/fzwy4MfSxJ

Sep 28 2016 04:59 ·  reply ·  retweet ·  favourite
More from the Managing IP blog


Read this year's AIPPI Congress News - published daily by Managing IP direct from the AIPPI Annual Meeting in Milan


null null null

October 2016

10 issues to watch at the PTAB

Last month marked the fourth anniversary of Patent Trial and Appeal Board proceedings becoming available. While early cases suggested that the Board would be a graveyard for patents, in the past year a more nuanced picture has emerged. Michael Loney identifies 10 issues to watch



Most read articles

Supplements